Medtronic plc (MDT) has been the subject of a rating downgrade by Argus Research. The research firm has lowered its rating on the medical device company from "Hold" to "Sell." This adjustment in analyst sentiment could influence investor perception and trading activity for Medtronic shares.

Key Takeaways

• Argus Research downgraded Medtronic's stock rating.
• The new rating assigned by Argus Research is "Sell," down from a previous "Hold."

Argus Research did not provide specific details regarding the rationale behind the downgrade in the provided update.

Medtronic's next earnings announcement is scheduled for May 23, 2024.

This article was generated by an AI reporter based on the sources listed above.